Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
---|
12/02/2008 | US7460182 Circuit for processing video signal including information such as caption |
12/02/2008 | US7459431 Recombinant gelatin-like proteins for use as plasma expanders |
12/02/2008 | US7459166 Anti-ageing effect |
12/02/2008 | US7459018 Injectable calcium phosphate cement |
12/02/2008 | CA2492417C Formulation for menopausal women |
12/02/2008 | CA2205085C An in vitro system for determining formation of a.beta. amyloid |
11/27/2008 | WO2008144738A1 Method for pain control |
11/27/2008 | WO2008144543A2 Compositions and methods for establishing and/or maintaining pregnancy |
11/27/2008 | WO2008143545A1 Agent for stimulating lymphatic drainage |
11/27/2008 | WO2008141570A1 A composition for improving quality of fetus, preventing and treating birth defects |
11/27/2008 | WO2008121826A3 Method for the treatment of fabry disease using pharmacological chaperones |
11/27/2008 | WO2008090471A3 Use of compositions comprising at least one alfa3 beta4 nachr antagonist such as mecamylamine in the treatment of gastrointestinal disorders |
11/27/2008 | WO2008073614A3 Composition and method for enhancing skin cell growth, proliferation and repair |
11/27/2008 | WO2008058210B1 Local administration of gallium compositions to treat pain |
11/27/2008 | US20080293847 Disinfecting polymer and articles made therefrom |
11/27/2008 | US20080292872 Substrate with a photocatalytic coating |
11/27/2008 | US20080292731 Method for pain control |
11/27/2008 | US20080292730 Nutritional supplement for osteoarthritis |
11/27/2008 | US20080292729 Stabilized Chlorite Solutions in Combination with Fluoropyrimidines for Cancer Treatment |
11/27/2008 | US20080292728 Cosmetic composition |
11/27/2008 | US20080292726 Ophthalmic gallium compositions and methods of their use |
11/27/2008 | US20080292724 Composition for improving membrane composition and functioning cells |
11/27/2008 | US20080292720 Cholesterol-interacting layered phyllosilicates and methods of reducing hypercholesteremia in a mammal |
11/27/2008 | US20080292719 Method of Treating Metabolic Syndrome |
11/27/2008 | US20080292718 Method for Suppression Appetite and Food Intake |
11/27/2008 | US20080292717 Highly Stable Aqueous Solution, Electrode with Nanocoating for Preparing the Solution and Method for Making this Electrode |
11/27/2008 | US20080292716 Electrolytic Water and Process for Production Thereof |
11/27/2008 | US20080292666 Preparation for Preventing or Treating Calcium Deficiency Conditions In Mammals |
11/27/2008 | US20080292649 Composition for improving membrane composition and functioning of cells |
11/27/2008 | US20080292626 Kinesin inhibitors |
11/27/2008 | US20080292613 Food Supplement Based on Group B Vitamins, Trace Elements and -3 and/or 6- Fatty Acids and Use of This Food Supplement in the Simultaneous Treatment of Localized Cellulite and Slackening of the Skin |
11/27/2008 | US20080292607 Nutraceutical agent for attenuating the neurodegenerative process associated with Parkinson's disease |
11/27/2008 | DE10251709B4 Screening-Verfahren für Wirkstoffe zur Stimulierung der humanen beta-Defensine vom Typ 2 und/oder Typ 3 Screening method for agents to stimulate the human beta-defensins type 2 and / or type 3 |
11/27/2008 | DE102007024802A1 Use of an active substance mixture comprising a fraction specific peptide and fraction essential and non-essential amino acids for the production of a composition to treat, prophylaxis and/or metaphylaxis of e.g. dementia disease |
11/27/2008 | CA2724833A1 Use of seleneium yeast composition for establishing and/or maintaining pregnancy |
11/27/2008 | CA2688863A1 Method for pain control |
11/27/2008 | CA2687545A1 Agent for stimulating lymphatic drainage |
11/26/2008 | EP1994940A1 Therapeutic use of a recombinant erythropoietin having high activity and reduced side effects |
11/26/2008 | EP1994937A2 Prevention and treatment of amyloidogenic disease |
11/26/2008 | EP1994935A1 Use of xenon to protect organs against ischaemic damage |
11/26/2008 | EP1993619A2 Pharmaceutical formulations comprising polyanionic materials and zinc-based preservatives |
11/26/2008 | EP1993607A2 Pharmaceutical compositions and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases |
11/26/2008 | EP1993572A2 Methods of treating or preventing sinusitis with oxidative reductive potential water solution |
11/26/2008 | EP1993571A2 Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution |
11/26/2008 | EP1993570A2 Methods of treating or preventing peritonitis with oxidative reductive potential water solution |
11/26/2008 | EP1993569A1 Anti-aging treatment using copper and zinc compositions |
11/26/2008 | EP1993567A2 Orally administrable gallium compositions and method of use |
11/26/2008 | EP1993566A1 Protease inhibitor for wound treatment |
11/26/2008 | EP1993514A2 Granular material comprising water-insoluble inorganic phosphate binders |
11/26/2008 | EP1993382A2 All natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and biological utilization |
11/26/2008 | EP1883641B1 Phthalocyanine derivatives, process for their preparation, pharmaceutical compositions containing them, and their use |
11/26/2008 | EP1706122B1 Anti-viral pharmaceutical compositions |
11/26/2008 | EP1523239B1 Use of a composition and a cleaning tablet containing said composition for disinfecting purposes |
11/26/2008 | EP1370228B1 Systems for delivering a cosmetic and/or therapeutic active to oral surfaces |
11/26/2008 | EP1328267B1 Method of treating cancer using dithiocarbamate derivatives |
11/26/2008 | CN101312746A Preparation containing iron(iii)-complexes and redox substances |
11/26/2008 | CN101312734A A therapeutic composition containing an organosilane quaternary compound and hydrogen peroxide for treating skin disorders |
11/26/2008 | CN101312712A Intravenous essential fatty acid emulsion |
11/26/2008 | CN101310757A Plaster for treating tinea corporis and tinea on manus and pedes |
11/26/2008 | CN101310755A Medicine for promoting the quick cure of fracture and preparation method thereof |
11/26/2008 | CN101310753A Analgesic and anticancer plaster and preparation method thereof |
11/26/2008 | CN101310748A Ointment for treating empyrosis |
11/26/2008 | CN101310740A Anti-anxiety compound traditional Chinese medicine and preparation method thereof |
11/26/2008 | CN101310736A External medicine for treating coronary heart disease and preparation method thereof |
11/26/2008 | CN101310727A Alcohol-containing chlorhexidine iodine disinfectant and preparation method thereof |
11/26/2008 | CN101310726A Alcohol-containing polyhexamethylguanidine iodine disinfectant and preparation method thereof |
11/26/2008 | CN101310724A Uses of adenosine a2alpha receptor antagonists |
11/26/2008 | CN101310719A Combination chemotherapy |
11/26/2008 | CN100435829C Chinese herbal medicine composition of regulating human body endocrine and face beautifying spot eliminating |
11/26/2008 | CN100435817C Medicine for treating rheumatism and rheumatoid diseases and preparing method |
11/26/2008 | CN100435808C Chinese medicine for treating dermatosis and tumor |
11/26/2008 | CN100435807C Pharmaceutical gel composition |
11/26/2008 | CN100435756C Arsenic trioxide control release elution stent |
11/25/2008 | US7455854 Fluid swellable fibrous matrix containing minerals; artificial bone |
11/25/2008 | CA2383212C Controlled release oral dosage suitable for oral administration |
11/25/2008 | CA2345354C Antisense modulation of bcl-x expression |
11/25/2008 | CA2276606C Method of treating prostatic diseases using active vitamin d analogues |
11/20/2008 | WO2008140974A1 Anti-microbial composition and method for making and using same |
11/20/2008 | WO2008140831A2 Iron/iron oxide nanoparticle and use thereof |
11/20/2008 | WO2008140572A2 Inorganic solids that accelerate coagulation of blood |
11/20/2008 | WO2008140262A2 Use of biological surfactant as anti -inflammatory agent and tissue preservative solution. |
11/20/2008 | WO2008140064A1 Nutrient composition for prevention and amelioration of lifestyle-related disease |
11/20/2008 | WO2008139078A2 Gaseous mixture containing o2 and n2o for preventing or reducing hyperalgesia |
11/20/2008 | WO2008118387A3 Erythrocyte atp-release modulators |
11/20/2008 | WO2008080092A3 Compositions comprising bile acid sequestrants for treating esophageal disorders |
11/20/2008 | WO2008068533A3 Antimicrobial composition |
11/20/2008 | WO2007127273A3 Methods and compositions for altering cell function |
11/20/2008 | US20080287861 Device and method for treatment of wounds with nitric oxide |
11/20/2008 | US20080287357 Conjugate Comprising P21 Protein for the Treatment of Cancer |
11/20/2008 | US20080286383 Incinerating, cooling, then treating with alkaline solution while applying heat; construction materials, semiconductor wafers, plant fertilizers |
11/20/2008 | US20080286382 Selenium, selenized yeast; gene expression inhibition |
11/20/2008 | US20080286381 biodrug comprising a nucleic acid sequence of nucleic acid; anticarcinogenic agents or antitumor agents; including cisplatin and carboplatin; effective chemotherapeutic agents in efficiency, being less invasive or toxic, and increased rate of recovery |
11/20/2008 | US20080286366 mammal blood platelet containing polyethyleneimine ( PEI) based nanoparticles (prepared by incubating PEI with green fluorescent protein (GFP) plasmid DNA) containing an active agent such as antibacterial, antiviral agent, blood coagulation protein, gene etc. drug delivery to sites of vascular injury |
11/20/2008 | US20080286357 Multi-functional particulate delivery system for pharmacologically active ingredients |
11/20/2008 | US20080286335 Enhancement Of The Calcium Sensing Receptor |
11/20/2008 | US20080286273 Knowledge-Based Proliferation Signatures and Methods of Use |
11/20/2008 | US20080286264 Modulation of Muc1 Activity |
11/20/2008 | US20080286261 Methods of modulating hair growth |
11/20/2008 | US20080286258 Bifeprunox mesylate maintenance dose compositions and methods for using the same |
11/20/2008 | US20080286254 Composition comprising licorice polyphenol |